Ipilimumab treatment decreases circulating Tregs and GrMDSC while enhancing CD4+ T cell activation

Yago Pico de Coaña, Maria Wolodarski, Giusy Gentilcore, Yuya Yoshimoto, Isabel Poschke, Johan Hansson, Giuseppe V. Masucci, Rolf Kiessling

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1
Number of pages1
JournalJournal of Translational Medicine
DOIs
Publication statusAccepted/In press - 15 Jan 2015
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Pico de Coaña, Y., Wolodarski, M., Gentilcore, G., Yoshimoto, Y., Poschke, I., Hansson, J., Masucci, G. V., & Kiessling, R. (Accepted/In press). Ipilimumab treatment decreases circulating Tregs and GrMDSC while enhancing CD4+ T cell activation. Journal of Translational Medicine, 1. https://doi.org/10.1186/1479-5876-13-S1-O7